Johnson & Johnson’s (J&J) groundbreaking cancer immunotherapy, Darzalex (daratumumab), has achieved a pivotal milestone in its European market penetration with…
Read More
Viz.ai and Alnylam Forge Strategic Alliance to Revolutionize Cardiac Amyloidosis Diagnosis and Care
In a significant development poised to reshape the landscape of cardiovascular medicine, Viz.ai has announced a groundbreaking collaboration with Alnylam…
Read More
